Pelgraz 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
amended 
on 
IB/0048 
B.II.f.1.d - Stability of FP - Change in storage 
13/09/2023 
SmPC and PL 
conditions of the finished product or the 
diluted/reconstituted product 
IB/0046 
B.I.b.1.c - Change in the specification parameters 
29/08/2023 
n/a 
and/or limits of an AS, starting 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
material/intermediate/reagent - Addition of a new 
specification parameter to the specification with its 
corresponding test method 
IB/0045 
B.I.a.4.b - Change to in-process tests or limits 
18/08/2023 
n/a 
applied during the manufacture of the AS - Addition 
of a new in-process test and limits 
IA/0047 
B.II.e.6.b - Change in any part of the (primary) 
09/08/2023 
n/a 
packaging material not in contact with the finished 
product formulation - Change that does not affect 
the product information 
R/0040 
Renewal of the marketing authorisation. 
26/04/2023 
23/06/2023 
SmPC, Annex 
Based on the review of data on quality, safety and efficacy, 
II, Labelling 
the CHMP considered that the benefit-risk balance of 
and PL 
Pelgraz in the approved indication remains favourable and 
therefore recommended the renewal of the marketing 
authorisation with unlimited validity. 
IB/0044/G 
This was an application for a group of variations. 
30/05/2023 
n/a 
B.II.e.2.b - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Addition of a new specification 
parameter to the specification with its corresponding 
test method 
B.II.e.2.b - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Addition of a new specification 
parameter to the specification with its corresponding 
test method 
B.III.2.z - Change to comply with Ph. Eur. or with a 
Page 2/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
national pharmacopoeia of a Member State - Other 
variation 
B.II.e.2.b - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Addition of a new specification 
parameter to the specification with its corresponding 
test method 
IB/0043/G 
This was an application for a group of variations. 
26/05/2023 
n/a 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
IB/0042/G 
This was an application for a group of variations. 
20/04/2023 
23/06/2023 
SmPC, 
B.II.e.7.b - Change in supplier of packaging 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
B.II.e.4.c - Change in shape or dimensions of the 
container or closure (immediate packaging) - Sterile 
medicinal products 
Labelling and 
PL 
Page 3/14 
 
 
 
 
 
 
 
 
 
 
 
 
B.II.e.4.c - Change in shape or dimensions of the 
container or closure (immediate packaging) - Sterile 
medicinal products 
B.II.e.6.a - Change in any part of the (primary) 
packaging material not in contact with the finished 
product formulation - Change that affects the 
product information 
IA/0041 
A.7 - Administrative change - Deletion of 
23/01/2023 
23/06/2023 
Annex II and 
manufacturing sites 
PL 
IA/0039 
B.II.e.7.b - Change in supplier of packaging 
29/11/2022 
n/a 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
IB/0037 
B.II.b.3.z - Change in the manufacturing process of 
25/10/2022 
n/a 
the finished or intermediate product - Other variation 
PSUSA/2326/
Periodic Safety Update EU Single assessment - 
29/09/2022 
n/a 
PRAC Recommendation - maintenance 
202201 
pegfilgrastim 
IB/0036/G 
This was an application for a group of variations. 
14/06/2022 
n/a 
B.I.b.1.z - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Other variation 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
IB/0034/G 
This was an application for a group of variations. 
09/02/2022 
n/a 
Page 4/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
IB/0032/G 
This was an application for a group of variations. 
13/12/2021 
n/a 
B.I.a.2.z - Changes in the manufacturing process of 
the AS - Other variation 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.a.2.z - Changes in the manufacturing process of 
the AS - Other variation 
IA/0033 
B.II.e.6.b - Change in any part of the (primary) 
12/11/2021 
n/a 
packaging material not in contact with the finished 
product formulation - Change that does not affect 
the product information 
IB/0031 
B.I.b.1.z - Change in the specification parameters 
27/09/2021 
n/a 
and/or limits of an AS, starting 
material/intermediate/reagent - Other variation 
IB/0030/G 
This was an application for a group of variations. 
18/08/2021 
n/a 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
Page 5/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
changes to an approved test procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
IB/0029 
C.I.2.a - Change in the SPC, Labelling or PL of a 
15/07/2021 
SmPC, 
Update of safety information following assessment of the 
generic/hybrid/biosimilar products following 
Labelling and 
same change for the reference product. 
assessment of the same change for the reference 
PL 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
IAIN/0028 
B.II.b.1.a - Replacement or addition of a 
12/05/2021 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
IA/0027 
B.II.e.7.b - Change in supplier of packaging 
29/04/2021 
n/a 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
IB/0026 
C.I.2.a - Change in the SPC, Labelling or PL of a 
23/04/2021 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
IA/0025 
B.I.b.2.a - Change in test procedure for AS or 
13/04/2021 
n/a 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
SmPC, 
Labelling and 
PL 
Page 6/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IB/0023 
B.I.a.2.z - Changes in the manufacturing process of 
18/02/2021 
n/a 
the AS - Other variation 
IAIN/0024/G 
This was an application for a group of variations. 
08/02/2021 
n/a 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
IB/0022/G 
This was an application for a group of variations. 
20/11/2020 
n/a 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.a.2.z - Changes in the manufacturing process of 
the AS - Other variation 
IB/0020/G 
This was an application for a group of variations. 
14/08/2020 
n/a 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.4.c - Change to in-process tests or limits 
applied during the manufacture of the AS - Deletion 
of a non-significant in-process test 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
Page 7/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.III.2.b - Change to comply with Ph. Eur. or with a 
national pharmacopoeia of a Member State - Change 
to comply with an update of the relevant monograph 
of the Ph. Eur. or national pharmacopoeia of a 
Member State 
IB/0021/G 
This was an application for a group of variations. 
13/08/2020 
n/a 
B.I.a.2.z - Changes in the manufacturing process of 
the AS - Other variation 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IB/0018/G 
This was an application for a group of variations. 
15/07/2020 
n/a 
B.II.d.1.z - Change in the specification parameters 
and/or limits of the finished product - Other variation 
B.II.d.2.d - Change in test procedure for the finished 
product - Other changes to a test procedure 
Page 8/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
(including replacement or addition) 
IB/0019 
B.I.a.2.z - Changes in the manufacturing process of 
26/06/2020 
n/a 
the AS - Other variation 
IB/0017 
B.I.a.1.z - Change in the manufacturer of AS or of a 
26/05/2020 
n/a 
starting material/reagent/intermediate for AS - Other 
variation 
IAIN/0016/G 
This was an application for a group of variations. 
17/04/2020 
16/04/2021 
Annex II and 
PL 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
IA/0014 
B.I.b.1.c - Change in the specification parameters 
31/01/2020 
n/a 
and/or limits of an AS, starting 
material/intermediate/reagent - Addition of a new 
specification parameter to the specification with its 
corresponding test method 
II/0013/G 
This was an application for a group of variations. 
05/12/2019 
n/a 
B.I.a.3.c - Change in batch size (including batch size 
ranges) of AS or intermediate - The change requires 
Page 9/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
assessment of the comparability of a 
biological/immunological AS 
B.I.c.1.a - Change in immediate packaging of the AS 
- Qualitative and/or quantitative composition 
B.II.b.4.a - Change in the batch size (including batch 
size ranges) of the finished product - Up to 10-fold 
compared to the originally approved batch size 
PSUSA/2326/
Periodic Safety Update EU Single assessment - 
19/09/2019 
22/11/2019 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
201901 
pegfilgrastim 
the variation to terms of the Marketing Authorisation(s)’ for 
PSUSA/2326/201901. 
II/0011/G 
This was an application for a group of variations. 
17/10/2019 
n/a 
B.I.a.2.c - Changes in the manufacturing process of 
the AS - The change refers to a [-] substance in the 
manufacture of a biological/immunological substance 
which may have a significant impact on the medicinal 
product and is not related to a protocol 
B.I.c.1.a - Change in immediate packaging of the AS 
- Qualitative and/or quantitative composition 
IB/0012/G 
This was an application for a group of variations. 
07/08/2019 
n/a 
B.I.a.4.c - Change to in-process tests or limits 
applied during the manufacture of the AS - Deletion 
of a non-significant in-process test 
B.I.a.4.c - Change to in-process tests or limits 
applied during the manufacture of the AS - Deletion 
of a non-significant in-process test 
B.I.a.4.c - Change to in-process tests or limits 
applied during the manufacture of the AS - Deletion 
Page 10/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
of a non-significant in-process test 
B.I.a.4.c - Change to in-process tests or limits 
applied during the manufacture of the AS - Deletion 
of a non-significant in-process test 
B.I.a.4.f - Change to in-process tests or limits 
applied during the manufacture of the AS - Addition 
or replacement of an in-process test as a result of a 
safety or quality issue 
B.I.a.4.f - Change to in-process tests or limits 
applied during the manufacture of the AS - Addition 
or replacement of an in-process test as a result of a 
safety or quality issue 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
IB/0010/G 
This was an application for a group of variations. 
02/08/2019 
n/a 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.b.2.a - Change in test procedure for AS or 
Page 11/14 
 
 
 
 
 
 
 
 
 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IB/0009 
B.I.a.z - Change in manufacture of the AS - Other 
29/07/2019 
n/a 
variation 
II/0005 
B.II.e.1.b.2 - Change in immediate packaging of the 
25/07/2019 
22/11/2019 
SmPC, Annex 
finished product - Change in type/addition of a new 
container - Sterile medicinal products and 
biological/immunological medicinal products 
II, Labelling 
and PL 
IB/0007/G 
This was an application for a group of variations. 
28/05/2019 
n/a 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
Page 12/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.a.4.c - Change to in-process tests or limits 
applied during the manufacture of the AS - Deletion 
of a non-significant in-process test 
B.I.a.1.z - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - Other 
variation 
B.I.a.4.f - Change to in-process tests or limits 
applied during the manufacture of the AS - Addition 
or replacement of an in-process test as a result of a 
safety or quality issue 
IB/0006 
B.II.b.2.a - Change to importer, batch release 
19/03/2019 
n/a 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
T/0003 
Transfer of Marketing Authorisation 
18/01/2019 
11/03/2019 
SmPC, 
Labelling and 
PL 
IB/0004 
B.I.b.2.e - Change in test procedure for AS or 
22/02/2019 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
II/0002 
B.II.b.2.b - Change to importer, batch release 
07/02/2019 
n/a 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place for a biol/immunol 
product and any of the test methods at the site is a 
biol/immunol method 
Page 13/14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IAIN/0001/G 
This was an application for a group of variations. 
06/11/2018 
11/03/2019 
Annex II and 
PL 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
B.II.e.7.b - Change in supplier of packaging 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
Page 14/14 
 
 
 
 
 
 
 
 
 
 
